A Study to Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN)
Clinical trial NCT00539838 · TERMINATED
Trial details
- NCT number
- NCT00539838
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-19
- Primary completion
- 2011-07-12
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.